Novonesis
381.10 DKK
+0.45 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
+0.45 %
+6.78 %
-8.89 %
-6.55 %
-6.41 %
-7.03 %
+10.78 %
-6.16 %
+930.00 %
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
178.47B DKK
Turnover
323.47M DKK
Revenue
31.05B
EBIT %
19.64 %
P/E
40.82
Dividend yield-%
1.12 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8
2026
Interim report Q2'26
All
Research
Press releases
ShowingAll content types
HCA Morgenbørs 27/03 - Udskudt deadline og grønne futures
Trading by management and close relations of management
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
